Skip to main content
Premium Trial:

Request an Annual Quote

Ultraflex MALDI-TOF, SPR/MS system, Omniflex LT & AMS 90 SE


At Pittcon last week in New Orleans, Bruker Daltonics announced the release of three new instrument systems and additional bioinformatics software for use in proteomics research. The Billerica, Mass.-based company now offers: the Ultraflex MALDI-TOF, a higher resolution version of the Reflex IV with the option for an upgrade to TOF/TOF capability; a combined SPR/MS system developed in collaboration with Biacore that combines surface plasmon resonance technology with Bruker’s Autoflex MALDI-TOF mass spectrometer; and the Omniflex LT, a low-end benchtop MALDI-TOF system priced at $89,900. In addtion, Bruker has released an atmospheric-pressure MALDI accessory for its Esquire 3000 plus ion trap and BioTOF Q-q-TOF systems. The company has also upgraded its ProteinScape web-based data storage and analysis software, released Biotools version 2.1 for protein data interpretation, and released HyStar version 2.2 software for managing LC/MS experiments.


Also at Pittcon, Thermo Finnigan announced the release of several new mass spectrometry and chromatography instruments, along with accompanying software, including the AI 3000/AS 3000 auto injection and auto sampler single channel GC; BioWorks 3.0 protein identification software; DeNovoX fully automated de novo sequencing software; Mass Frontier 3.0 application software for interpreting mass spectra; ProteomeX LC/MS workstation for protein and peptide analysis and purification; Surveyor MSQ benchtop single quad LC/MS; and TRACE MS Plus benchtop single quad GC/MS; and UltraFast GC module.


Caliper Technologies has released a new protein assay for its AMS 90 SE automated microfluidics system. The product includes the Protein Assay LabChip device, which the company said is capable of performing 1,000 protein mixture separations, plus a standard protein size and quantitation ladder, software, reagents, documentation and support.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.